163 related articles for article (PubMed ID: 19558634)
1. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism.
Laje P; Halaby L; Adzick NS; Stanley CA
Pediatr Diabetes; 2010 Mar; 11(2):142-7. PubMed ID: 19558634
[TBL] [Abstract][Full Text] [Related]
2. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
[TBL] [Abstract][Full Text] [Related]
3. Is octreotide a risk factor in necrotizing enterocolitis?
Reck-Burneo CA; Parekh A; Velcek FT
J Pediatr Surg; 2008 Jun; 43(6):1209-10. PubMed ID: 18558210
[TBL] [Abstract][Full Text] [Related]
4. Late Presentation of Fulminant Necrotizing Enterocolitis in a Child with Hyperinsulinism on Octreotide Therapy.
Hawkes CP; Adzick NS; Palladino AA; De León DD
Horm Res Paediatr; 2016; 86(2):131-136. PubMed ID: 26867223
[TBL] [Abstract][Full Text] [Related]
5. Octreotide-induced severe paradoxical hyperglycemia and bradycardia during subtotal pancreatectomy for congenital hyperinsulinism in an infant.
Batra YK; Rajeev S; Samra T; Rao KL
Paediatr Anaesth; 2007 Nov; 17(11):1117-9. PubMed ID: 17897286
[No Abstract] [Full Text] [Related]
6. Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?
Chandran S; Agarwal A; Llanora GV; Chua MC
BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32051156
[TBL] [Abstract][Full Text] [Related]
7. Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).
Hussain K; Aynsley-Green A; Stanley CA
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():163-7. PubMed ID: 16456495
[TBL] [Abstract][Full Text] [Related]
8. Is octreotide safe for the management of persistent hyperinsulinemic hypoglycemia of infancy?
Abdel Khalek M; Kandil E
Eur J Pediatr Surg; 2011 May; 21(3):188-9. PubMed ID: 21283963
[No Abstract] [Full Text] [Related]
9. Octreotide use and safety in infants with hyperinsulinism.
McMahon AW; Wharton GT; Thornton P; De Leon DD
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):26-31. PubMed ID: 27910218
[TBL] [Abstract][Full Text] [Related]
10. Glucose metabolism and neurological outcome in congenital hyperinsulinism.
Ludwig A; Ziegenhorn K; Empting S; Meissner T; Marquard J; Holl R; ; Mohnike K
Semin Pediatr Surg; 2011 Feb; 20(1):45-9. PubMed ID: 21186004
[TBL] [Abstract][Full Text] [Related]
11. Late presentation of necrotizing enterocolitis associated with rotavirus infection in a term infant with hyperinsulinism on octreotide therapy: A case report.
Alsaedi AA; Bakkar AA; Kamal NM; Althobiti JM
Medicine (Baltimore); 2017 Oct; 96(40):e7949. PubMed ID: 28984754
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy.
Al-Shanafey S; Habib Z; AlNassar S
J Pediatr Surg; 2009 Jan; 44(1):134-8; discussion 138. PubMed ID: 19159730
[TBL] [Abstract][Full Text] [Related]
13. Octreotide-induced hepatitis in a child with persistent hyperinsulinemia hypoglycemia of infancy.
Ben-Ari J; Greenberg M; Nemet D; Edelstein E; Eliakim A
J Pediatr Endocrinol Metab; 2013; 26(1-2):179-82. PubMed ID: 23327813
[TBL] [Abstract][Full Text] [Related]
14. Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates.
Arevalo RP; Bullabh P; Krauss AN; Auld PA; Spigland N
J Pediatr Surg; 2003 Feb; 38(2):251-3. PubMed ID: 12596116
[TBL] [Abstract][Full Text] [Related]
15. [Congenital hyperinsulinism of infancy: surgical treatment in 60 cases of focal form].
Crétolle C; de Lonlay P; Sauvat F; Brunelle F; Rahier J; Saudubray JM; Nihoul-Fékété C
Arch Pediatr; 2005 Mar; 12(3):258-63. PubMed ID: 15734120
[TBL] [Abstract][Full Text] [Related]
16. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
Vallurupalli S
Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
[TBL] [Abstract][Full Text] [Related]
17. Treatment of postoperative enterocutaneous fistulas with octreotide in two neonates.
Karabulut R; Karakuş C; Hirfanoğlu I; Turan O; Türkyilmaz Z; Sönmez K; Onal EE; Atalay Y; Başaklar AC
Eur J Pediatr Surg; 2008 Feb; 18(1):56-8. PubMed ID: 18302073
[TBL] [Abstract][Full Text] [Related]
18. The surgical management of atypical forms of congenital hyperinsulinism.
Capito C; de Lonlay P; Verkarre V; Jaubert F; Rahier J; Nihoul-Fékété C; Aigrain Y
Semin Pediatr Surg; 2011 Feb; 20(1):54-5. PubMed ID: 21186006
[TBL] [Abstract][Full Text] [Related]
19. Octreotide in a Critically Ill Extremely Preterm Infant With Perforated Necrotizing Enterocolitis.
Martini S; Aceti A; Lima M; Maffi M; Faldella G; Corvaglia L
Pediatrics; 2016 Aug; 138(2):. PubMed ID: 27405769
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic diagnosis and cure of hyperinsulinism in two cases of focal adenomatous hyperplasia in infancy.
De Vroede M; Bax NM; Brusgaard K; Dunne MJ; Groenendaal F
Pediatrics; 2004 Oct; 114(4):e520-2. PubMed ID: 15466080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
